-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Centessa Pharmaceuticals plc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2021 to Q2 2024.
- Centessa Pharmaceuticals plc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 109M shares, a 15.1% increase year-over-year.
- Centessa Pharmaceuticals plc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 96.2M shares, a 2.97% increase from 2022.
- Centessa Pharmaceuticals plc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 93.4M shares, a 24.3% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)